Completed PHASE4 INTERVENTIONAL 2-arm NCT00560612

Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD)

Sponsor: Durham VA Medical Center

Conditions Stress Disorders, Post-Traumatic

Updated 8 times since 2017 Last updated: May 24, 2019 Started: Jan 31, 2006 Primary completion: Jul 31, 2008 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00560612, this PHASE4 trial focuses on Stress Disorders, Post-Traumatic and remains completed. Sponsored by Durham VA Medical Center, it has been updated 8 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jul 2019 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Jul 2019 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Durham VA Medical Center

Data source: Durham VA Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States